Processa Pharmaceuticals, Inc. Shares Outstanding (Cover Page)
Processa Pharmaceuticals, Inc. (PCSA) had Shares Outstanding (Cover Page) of 2.79 million shares as of 2026-08-07, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-07: Entity Common Stock, Shares Outstanding 2.79M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 2.75M shares.
- 2026-04-29: Entity Common Stock, Shares Outstanding 2.74M shares.
- 2026-03-13: Entity Common Stock, Shares Outstanding 2.66M shares.
| Period end | Entity Common Stock, Shares Outstanding | Entity Common Stock, Shares Outstanding as first filed |
|---|---|---|
| 2026-08-07 | 2.79M shares 10-Q · filed 2026-08-14 | |
| 2026-05-01 | 2.75M shares 10-Q · filed 2026-05-07 | |
| 2026-04-29 | 2.74M shares 10-K/A · filed 2026-04-30 | |
| 2026-03-13 | 2.66M shares 10-K · filed 2026-03-18 | |
| 2025-11-03 | 56.64M shares 10-Q · filed 2025-11-06 | |
| 2025-08-05 | 50.35M shares 10-Q · filed 2025-08-07 | |
| 2025-05-08 | 11.88M shares 10-Q · filed 2025-05-08 | |
| 2025-03-12 | 5.27M shares 10-K · filed 2025-03-20 | |
| 2024-10-15 | 3.27M shares 10-Q · filed 2024-10-30 | |
| 2024-08-01 | 3.26M shares 10-Q · filed 2024-08-13 | |
| 2024-05-10 | 2.86M shares 10-Q · filed 2024-05-10 | |
| 2024-03-21 | 2.86M shares 10-K · filed 2024-03-29 | |
| 2023-11-01 | 24.63M shares 10-Q · filed 2023-11-13 | |
| 2023-08-04 | 24.53M shares 10-Q · filed 2023-08-10 | |
| 2023-05-09 | 24.53M shares 10-Q · filed 2023-05-15 | |
| 2023-03-27 | 24.56M shares 10-K · filed 2023-03-30 | |
| 2022-11-01 | 15.99M shares 10-Q · filed 2022-11-08 | |
| 2022-08-04 | 15.86M shares 10-Q · filed 2022-08-11 | |
| 2022-04-30 | 15.84M shares 10-Q · filed 2022-05-12 | |
| 2022-03-31 | 15.84M shares 10-K/A · filed 2022-05-02 | |
| 2022-03-24 | 15.84M shares 10-K · filed 2022-03-30 | |
| 2021-11-02 | 15.72M shares 10-Q · filed 2021-11-12 | |
| 2021-08-02 | 15.60M shares 10-Q · filed 2021-08-12 | |
| 2021-04-30 | 15.52M shares 10-Q · filed 2021-05-13 | |
| 2021-03-19 | 15.52M shares 10-K · filed 2021-03-25 | |
| 2020-10-31 | 10.57M shares 10-Q · filed 2020-11-12 | |
| 2020-07-31 | 5.52M shares 10-Q · filed 2020-08-05 | |
| 2020-04-30 | 5.49M shares 10-Q · filed 2020-05-15 | |
| 2020-02-28 | 5.49M shares 10-K · filed 2020-03-06 | |
| 2019-11-05 | 38.40M shares 10-Q · filed 2019-11-14 | |
| 2019-07-31 | 38.80M shares 10-Q · filed 2019-08-14 | |
| 2019-04-30 | 38.67M shares 10-Q · filed 2019-05-14 | |
| 2019-03-15 | 38.67M shares 10-K/A · filed 2019-04-08 | 35.27M shares 10-K · filed 2019-03-28 |
| 2018-11-13 | 38.67M shares 10-Q · filed 2018-11-14 | |
| 2018-08-02 | 38.67M shares 10-Q · filed 2018-08-14 | |
| 2018-05-21 | 35.27M shares 10-Q · filed 2018-05-21 | |
| 2018-04-13 | 35.27M shares 10-K · filed 2018-04-16 | |
| 2017-09-30 | 24.69M shares 10-Q · filed 2017-11-20 | |
| 2017-06-30 | 11.02M shares 10-Q · filed 2017-10-04 | |
| 2017-03-31 | 11.02M shares 10-Q · filed 2017-10-04 | |
| 2016-12-31 | 11.02M shares 10-K · filed 2017-09-25 | |
| 2016-09-30 | 11.02M shares 10-Q · filed 2017-09-08 | |
| 2016-06-30 | 11.02M shares 10-Q · filed 2017-08-30 | |
| 2016-03-31 | 11.02M shares 10-Q · filed 2017-08-07 | |
| 2015-12-31 | 11.02M shares 10-K · filed 2017-06-19 | |
| 2015-09-30 | 11.02M shares 10-Q · filed 2015-12-01 | |
| 2015-06-30 | 11.02M shares 10-Q · filed 2015-08-19 | |
| 2015-03-31 | 11.06M shares 10-Q · filed 2015-05-15 | |
| 2014-12-31 | 9.50M shares 10-K · filed 2015-04-14 | |
| 2014-09-30 | 8.43M shares 10-Q · filed 2014-11-13 | |
| 2014-06-30 | 8.43M shares 10-Q · filed 2014-08-19 | |
| 2014-03-31 | 8.27M shares 10-Q · filed 2014-05-14 | |
| 2013-12-31 | 8.08M shares 10-K · filed 2014-03-27 | |
| 2013-09-30 | 8.05M shares 10-Q · filed 2013-11-08 | |
| 2013-06-30 | 7.03M shares 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |